Platelet inhibitor therapy. Agents and clinical implications.

Author: ChesebroJ H, FusterV, WebsterM W

Paper Details 
Original Abstract of the Article :
Platelets are central to the pathophysiology of an array of vascular disorders. Current platelet-inhibitor drugs reduce platelet aggregation through one of three pathways but do not prevent initial platelet adhesion. The most extensive clinical experience is with aspirin, an irreversible inhibitor o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2179212

データ提供:米国国立医学図書館(NLM)

Platelet Inhibitors: A Journey Through Thrombosis Prevention

Platelets play a central role in the development of blood clots, making platelet inhibitors crucial for preventing thromboembolic events. This research provides an overview of various platelet inhibitors, their mechanisms of action, and their clinical implications.

Unveiling the Mechanisms: A Spectrum of Platelet Inhibitors

The review explores the different pathways by which platelet inhibitors act, ranging from irreversible inhibition of cyclooxygenase (aspirin) to inhibition of ADP receptors (dipyridamole) and thrombin inhibitors (hirudin). This comprehensive overview highlights the diverse approaches to preventing platelet aggregation and its associated complications.

Protecting Hearts and Brains: Platelet Inhibitors in Action

Imagine a world where heart attacks and strokes are effectively prevented through the use of platelet inhibitors. This research emphasizes the critical role of these medications in preventing arterial thromboembolic disease. The review highlights the efficacy of aspirin in primary and secondary prevention of myocardial infarction, as well as its role in reducing thrombotic complications after coronary angioplasty and revascularization surgery.

Dr. Camel's Conclusion

This review delves into the fascinating world of platelet inhibitors, showcasing their diverse mechanisms of action and their significant contributions to preventing thromboembolic events. The research highlights the importance of these medications in protecting hearts and brains, underscoring their crucial role in cardiovascular health.

Date :
  1. Date Completed 1990-04-26
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

2179212

DOI: Digital Object Identifier

2179212

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.